Increased gene expression of liver SREBP-2 in experimental chronic renal failure

Atherosclerosis

Volumn 191, Issue 2, 2007, Pages 326-332

  Chmielewski, Michal ^a   Sucajtys Szulc, Elzbieta ^a   Kossowska, Ewa ^a   Swierczynski, Julian ^a   Rutkowski, Boleslaw ^a   Boguslawski, Wojciech ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Cholesterol synthesis; Chronic renal failure; HMG CoA reductase; Hypercholesterolemia; LDL receptor; Sterol regulatory element binding protein 2 (SREBP 2)

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIVER PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL SYNTHESIS; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; GENE EXPRESSION; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT;

ANIMALS; CHOLESTEROL; DISEASE MODELS, ANIMAL; ENZYME INDUCTION; GENE EXPRESSION; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYPERCHOLESTEROLEMIA; KIDNEY FAILURE, CHRONIC; LIVER; MALE; NEPHRECTOMY; RATS; RATS, WISTAR; RECEPTORS, LDL; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UP-REGULATION;

EID: 33947133748     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.05.044     Document Type: Article

References (29)

1. Oda H., and Keane W.F. Lipid abnormalities in end stage renal disease. Nephrol Dial Transplant 13 Suppl 1 (1998) 45-49
2. Chmielewski M., Sucajtys E., Swierczynski J., Rutkowski B., and Boguslawski W. Contribution of increased HMG-CoA reductase gene expression to hypercholesterolemia in experimental chronic renal failure. Mol Cell Biochem 246 1-2 (2003) 187-191
3. Szolkiewicz M., Sucajtys E., Chmielewski M., et al. Increased rate of cholesterologenesis-a possible cause of hypercholesterolemia in experimental chronic renal failure in rats. Horm Metab Res 34 (2002) 234-237
4. Chmielewski M., Nieweglowski T., Swierczynski J., Rutkowski B., and Boguslawski W. Diurnal rhythm of cholesterol biosynthesis in experimental chronic renal failure. Mol Cell Biochem 228 (2001) 33-37
5. Horton J.D., Goldstein J.L., and Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109 (2002) 1125-1131
6. Horton J.D., Shimomura I., Brown M.S., Hammer R.E., Goldstein J.L., and Shimano H. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J Clin Invest 101 (1998) 2331-2339
7. Miserez A.R., Muller P.Y., Barella L., et al. Sterol-regulatory element-binding protein (SREBP)-2 contributes to polygenic hypercholesterolaemia. Atherosclerosis 164 (2002) 15-26
8. Robinet P., Vedie B., Chironi G., et al. Characterization of polymorphic structure of SREBP-2 gene: role in atherosclerosis. Atherosclerosis 168 (2003) 381-387
9. Rodriguez C., Martinez-Gonzalez J., Sanchez-Gomez S., and Badimon L. LDL downregulates CYP51 in porcine vascular endothelial cells and in the arterial wall through a sterol regulatory element binding protein-2-dependent mechanism. Circ Res 88 (2001) 268-274
10. Korczynska J., Stelmanska E., Nogalska A., et al. Upregulation of lipogenic enzymes genes expression in white adipose tissue of rats with chronic renal failure is associated with higher level of sterol regulatory element binding protein-1. Metabolism 53 (2004) 1060-1065
11. Jiang T., Liebman S.E., Lucia M.S., Phillips C.L., and Levi M. Calorie restriction modulates renal expression of sterol regulatory element binding proteins, lipid accumulation, and age-related renal disease. J Am Soc Nephrol 16 (2005) 2385-2394
12. Sun L., Halaihel N., Zhang W., Rogers T., and Levi M. Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus. J Biol Chem 277 (2002) 18919-18927
13. Swierczynski J., Korczynska J., Szolkiewicz M., et al. Low leptin mRNA level in adipose tissue and normoleptinemia in experimental chronic renal failure. Exp Nephrol 9 (2001) 54-59
14. Kochan Z., Karbowska J., and Swierczynski J. Unususal increase of lipogenesis in rat white adipose tissue after multiple cycles of starvation-refeeding. Metabolism 46 (1997) 10-17
15. Sperry W., and Webb M. A revision of the Schoenheimer-Sperry method for cholesterol determination. J Biol Chem 187 (1950) 97-106
16. Shapiro D.J., Nordstrom J.L., Mitschelen J.J., Rodwell V.W., and Schimke R.T. Micro assay for 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblasts. Biochim Biophys Acta 370 (1974) 369-377
17. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
18. Freeman W.M., Walker S.J., and Vrana K.E. Quantitative RT-PCR: pitfalls and potential. Biotechniques 26 112-22 (1999) 24-25
19. Marone M., Mozzetti S., De Ritis D., Pierelli L., and Scambia G. Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample. Biol Proc Online 3 (2001) 19-25
20. Ide T., Ashakumary L., Takahashi Y., Kushiro M., Fukuda N., and Sugano M. Sesamin a sesame lignan, decreases fatty acid synthesis in rat liver accompanying the down-regulation of sterol regulatory element binding protein-1. Biochim Biophys Acta 1534 (2001) 1-13
21. Vaziri N.D., and Liang K.H. Acyl-coenzyme A: cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome. Circulation 110 (2004) 419-425
22. Liang K., Kim C.H., and Vaziri N.D. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure. Am J Physiol Renal Physiol 288 (2005) F539-F544
23. Hall E.A., Ren S., Hylemon P.B., et al. Mitochondrial cholesterol transport: a possible target in the management of hyperlipidemia. Lipids 40 (2005) 1237-1244
24. Eberle D., Hegarty B., Bossard P., Ferre P., and Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86 (2004) 839-848
25. Zoccali C., Mallamaci F., and Tripepi G. Inflammation and atherosclerosis in end-stage renal disease. Blood Purif 21 (2003) 29-36
26. Klahr S., and Morrissey J. Progression of chronic renal disease. Am J Kidney Dis 41 (2003) S3-S7
27. Luger A., Kovarik J., Stummvoll H.K., Urbanska A., and Luger T.A. Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int 32 (1987) 84-88
28. Ruan X.Z., Varghese Z., Powis S.H., and Moorhead J.F. Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation. Kidney Int 60 (2001) 1716-1725
29. Demoulin J.B., Ericsson J., Kallin A., Rorsman C., Ronnstrand L., and Heldin C.H. Platelet-derived growth factor stimulates membrane lipid synthesis through activation of phosphatidylinositol 3-kinase and sterol regulatory element-binding proteins. J Biol Chem 279 (2004) 35392-35402